Essential Tremor Guidelines Advisory

Essential Tremor Advisory - 2026 Update

IETF Essential Tremor GUIDELINES Advisory App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1380755

Contents of this Issue

Navigation

Page 5 of 17

6 Management Non-Pharmacological/Non-Surgical Treatment Options Wrist-worn Non-invasive Stimulation Transcutaneous Afferent Patterned Stimulation (TAPS) • Cala kIQ is an individualized, re-chargeable, non-invasive wrist-worn device to reduce tremor in a targeted arm. It provides electrical stimulation to the median and radial nerves through electrodes placed on the inside of a wrist band. • Cala kIQ was cleared by the Food and Drug Administration (FDA) in 2023 (Cala Trio cleared in 2018), and is indicated in adults with essential tremor to provide transient relief of hand tremors following stimulation. ▶ The wrist band device is worn for 40 minutes, after which 64% of patients reported having persistent relief for an average of 94 minutes. ▶ When starting therapy, patients should choose an activity (e.g. eating ) and use Cala kIQ 20–40 minutes prior. This usage should continue on-demand for at least 2 weeks to determine benefits. ▶ A typical charge will last for approximately 5 sessions. It takes approximately 3–4 hours to fully charge the device. ▶ It can be used with or without pharmacological therapies. • Cala kIQ is contraindicated in patients with implanted electrical devices such as a pacemaker, defibrillator, or deep brain stimulation device; patients with a seizure disorder; pregnant women; and in persons with skin irritations, open wounds, or lesions on the wrist.

Articles in this issue

view archives of Essential Tremor Guidelines Advisory - Essential Tremor Advisory - 2026 Update